Highlander Partners’s Merck MRK Stock Holding History

Highlander Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$424K	Hold	3,300	–	–	0.14%	29
2026 Q1	$397K	Hold	3,300	–	–	0.16%	29
2025 Q4	$347K	Hold	3,300	–	–	0.12%	35
2025 Q3	$277K	Hold	3,300	–	–	0.1%	40
2025 Q2	$261K	Hold	3,300	–	–	0.1%	42
2025 Q1	$296K	Hold	3,300	–	–	0.18%	36
2024 Q4	$328K	Hold	3,300	–	–	0.19%	28
2024 Q3	$333K	Hold	3,300	–	–	0.2%	26
2024 Q2	$370K	Hold	3,300	–	–	0.25%	24
2024 Q1	$428K	Buy	+3,300	New	+$407K	0.3%	21

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Highlander Partners's MRK Position: Q2 2026 in Review

Highlander Partners held its Merck (MRK) position steady in Q2 2026 at 3,300 shares worth $424K. The position accounts for 0.14% of the portfolio, ranked #29.

Highlander Partners first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. The position peaked at $428K in Q1 2024. 1,766 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Highlander Partners held 3,300 shares of Merck worth $424K as of Q2 2026.
Highlander Partners left its Merck share count unchanged in Q2 2026.
Merck made up 0.14% of Highlander Partners's portfolio in Q2 2026, its #29 holding.
Highlander Partners first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
Highlander Partners's Merck position peaked at $428K in Q1 2024.
1,766 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Highlander Partners's 13F filing for Q2 2026, filed 29 Jul 2026.